Sabine Mai
Founder chez TELO GENOMICS CORP.
Fortune : 233 266 $ au 31/03/2024
Profil
Sabine Mai is the founder of Telo Genomics Corp.
which was founded in 2011.
She holds the title of Director at Telo Genomics Corp.
Dr. Mai's current jobs include being a Director at The Genomic Centre For Cancer Research & Diagnosis and a Professor at the University of Manitoba.
Dr. Mai's former job was being a Director at 3D Signatures, Inc.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
TELO GENOMICS CORP.
3,95% | 08/12/2023 | 2 810 433 ( 3,95% ) | 233 266 $ | 31/03/2024 |
Postes actifs de Sabine Mai
| Sociétés | Poste | Début |
|---|---|---|
| TELO GENOMICS CORP. | Founder | 25/05/2011 |
| University of Manitoba | Corporate Officer/Principal | - |
| The Genomic Centre For Cancer Research & Diagnosis | Director/Board Member | - |
Anciens postes connus de Sabine Mai
| Sociétés | Poste | Fin |
|---|---|---|
3D Signatures, Inc. /Old/
 3D Signatures, Inc. /Old/ Medical/Nursing ServicesHealth Services 3D Signatures, Inc. develops diagnostic and prognostic products. It provides diagnostic and prognostic tools for cancer and Alzheimer's disease. 3D Signatures is in the process of developing 3D Telo-PC for prostate cancer and 3D Telo-RS for Hodgkin’s Lymphoma. The company is headquartered in Winnipeg, Canada. | Director/Board Member | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| TELO GENOMICS CORP. | Health Services |
| Entreprise privées | 2 |
|---|---|
3D Signatures, Inc. /Old/
3D Signatures, Inc. /Old/ Medical/Nursing ServicesHealth Services 3D Signatures, Inc. develops diagnostic and prognostic products. It provides diagnostic and prognostic tools for cancer and Alzheimer's disease. 3D Signatures is in the process of developing 3D Telo-PC for prostate cancer and 3D Telo-RS for Hodgkin’s Lymphoma. The company is headquartered in Winnipeg, Canada. | Health Services |
| The Genomic Centre For Cancer Research & Diagnosis |
